Research Directory

European biotechs post fourth annual advance

Read more

Pharma dealmaking has been smarter in 2015

Read more

Europe's new unitary patent

Read more

A US approach to value-based drug assessment

Read more

Innovation forces new thinking on drug pricing

Read more

A way forward for pricing new pharmaceuticals

Read more

Failure rate rises for late-stage oncology studies

Read more

Genome editing scrutinised around the globe

Read more

Gene editing - from research tool to therapy

Read more

New equity underpins biotech values in quarter

Read more